BRPI0811016A2 - Proteína li truncada do papiloma vírus humano tipo 16 - Google Patents

Proteína li truncada do papiloma vírus humano tipo 16

Info

Publication number: BRPI0811016A2
Authority: BR; Brazil
Prior art keywords: human virus; protein; type; human; virus
Prior art date: 2007-04-29

Application number

Other languages

English (en)

Inventor

Yung Gu

Shaowei Li

Minxi Wei

Yangling Xian

Wenxin Luo

Ningshao Xia

Original Assignee

Beijing Wantai Biological Pharmacy Entpr Co Ltd

Univ Xiamen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-29

Filing date

2008-04-29

Publication date

2015-01-27

2008-04-29 Application filed by Beijing Wantai Biological Pharmacy Entpr Co Ltd, Univ Xiamen filed Critical Beijing Wantai Biological Pharmacy Entpr Co Ltd

2015-01-27 Publication of BRPI0811016A2 publication Critical patent/BRPI0811016A2/pt

2021-09-21 Publication of BRPI0811016B1 publication Critical patent/BRPI0811016B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Mycology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI0811016-6A 2007-04-29 2008-04-29 Proteína li truncada do papiloma vírus humano tipo 16 BRPI0811016B1 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
CN200710097762.8		2007-04-29
CN200710097762		2007-04-29
CN200810008761		2008-01-23
CN200810008761.6		2008-01-23
PCT/CN2008/000872 WO2008134934A1 (fr)	2007-04-29	2008-04-29	Protéine l1 tronquée du papillomavirus 16 humain

Publications (2)

Publication Number	Publication Date
BRPI0811016A2 true BRPI0811016A2 (pt)	2015-01-27
BRPI0811016B1 BRPI0811016B1 (pt)	2021-09-21

Family

ID=39943110

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0811016-6A BRPI0811016B1 (pt)	2007-04-29	2008-04-29	Proteína li truncada do papiloma vírus humano tipo 16

Country Status (6)

Country	Link
US (1)	US9428555B2 (pt)
EP (1)	EP2154147B1 (pt)
CN (1)	CN101293918B (pt)
BR (1)	BRPI0811016B1 (pt)
DK (1)	DK2154147T3 (pt)
WO (1)	WO2008134934A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9364529B2 (en)	2007-04-29	2016-06-14	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	Truncated L1 protein of human papillomavirus type 18
DK2154147T3 (en)	2007-04-29	2015-12-07	Beijing Wantai Biological Pharmacy Entpr Co Ltd	Truncated L1 protein of human papillomavirus 16
CN101343315B (zh) *	2007-05-29	2012-06-13	厦门大学	截短的人乳头瘤病毒6型l1蛋白
WO2012000454A1 (zh) *	2010-07-02	2012-01-05	厦门大学	截短的人乳头瘤病毒52型l1蛋白
CN102229660B (zh) *	2011-05-25	2015-04-22	厦门大学	截短的人乳头瘤病毒33型l1蛋白
CN102747047B (zh) *	2012-02-28	2016-03-23	厦门大学	人乳头瘤病毒型别杂合病毒样颗粒及其制备方法
CN105002190B (zh) *	2013-12-03	2022-11-08	北京康乐卫士生物技术股份有限公司	11型重组人乳头瘤病毒病毒样颗粒及其制备方法
US10413603B2 (en) *	2014-06-19	2019-09-17	The Regents Of The University Of Colorado, A Body Corporate	Compositions, methods and uses for improved human papilloma virus constructs
KR101825996B1 (ko) *	2014-12-26	2018-02-09	아이진 주식회사	인유두종 바이러스의 바이러스 유사 입자 제조방법
CN107188932B (zh) *	2016-03-15	2020-02-11	中国医学科学院基础医学研究所	截短型人乳头瘤病毒16型l1蛋白及其应用
CN107188966B (zh)	2016-03-15	2020-03-31	中国医学科学院基础医学研究所	一种乳头瘤病毒嵌合蛋白及其用途
CN106884017B (zh) *	2016-12-28	2024-03-26	中国食品药品检定研究院	用于包装柯萨奇病毒b5假病毒的重组表达质粒、假病毒、试剂盒和方法
BR112020000833A2 (pt) *	2017-07-14	2020-07-21	Xiamen University	mutante de proteína l1 de papiloma vírus humano tipo 16
KR102803235B1 (ko) *	2018-06-04	2025-05-07	시아먼 유니버시티	타입 39 인유두종 바이러스 l1 단백질의 돌연변이체
WO2021013069A1 (zh) *	2019-07-19	2021-01-28	神州细胞工程有限公司	嵌合的人乳头瘤病毒11型l1蛋白
CN114716560B (zh)	2021-01-04	2024-02-02	中国医学科学院基础医学研究所	一种人乳头瘤病毒18型嵌合蛋白及其用途
CN114716561B (zh)	2021-01-04	2024-03-12	中国医学科学院基础医学研究所	一种人乳头瘤病毒31型嵌合蛋白及其用途
CN114292321B (zh) *	2021-12-30	2023-06-16	重庆澳龙生物制品有限公司	可溶性表达eg95蛋白及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1618888T3 (da)	1993-03-09	2011-04-04	Univ Rochester	Fremstilling af humant papillomvirus-capsidprotein og viruslignende partikler
AUPM566794A0 (en) *	1994-05-17	1994-06-09	University Of Queensland, The	Process and product
IL113817A (en) *	1994-06-30	2001-03-19	Merck & Co Inc	Polynucleotide vaccne for papillomavirus
DE122007000093I1 (de)	1994-10-07	2008-03-27	Univ Loyola Chicago	Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung
US5840306A (en) *	1995-03-22	1998-11-24	Merck & Co., Inc.	DNA encoding human papillomavirus type 18
IL117459A (en)	1995-03-22	2005-11-20	Merck & Co Inc	Dna encoding human papillomavirus type 18
US5820870A (en) *	1995-03-22	1998-10-13	Merck & Co., Inc.	Recombinant human papillomavirus type 18 vaccine
US6908615B1 (en) *	1996-03-18	2005-06-21	Merck & Co., Inc.	DNA encoding human papilloma virus type 18
US7351533B2 (en) *	1997-09-05	2008-04-01	Medimmune, Inc.	In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
US6228368B1 (en) *	1997-10-06	2001-05-08	Loyola University Of Chicago	Papilloma virus capsomere formulations and method of use
US7182947B2 (en) *	1998-02-20	2007-02-27	Medigene Ag	Papillomavirus truncated L1 protein and fusion protein constructs
US20020039584A1 (en) *	1998-02-20	2002-04-04	Medigene Ag	Papilloma virus capsomere vaccine formulations and methods of use
US20020193565A1 (en) *	1998-03-27	2002-12-19	Stanley Margaret Anne	Antigen preparation and use
BR9913026A (pt)	1998-08-14	2001-09-25	Merck & Co Inc	Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano
AU3730600A (en) *	1999-03-18	2000-10-04	Xiaojiang Chen	Compositions preparations and uses of human papillomavirus l1 protein
DE10059630A1 (de)	2000-12-01	2002-06-06	Medigene Ag	Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor
AP2004003021A0 (en)	2001-08-31	2004-06-30	Univ Cape Town	Vectors, constructs and transgenic plants for HPV-11 and HPV-16 L1 capsid protein.
GB0206360D0 (en) *	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
GB0206359D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
AU2003228816A1 (en)	2002-05-02	2003-11-17	Boyce Thompson Institute For Plant Research, Inc.	Production of papillomavirus vaccines in plants
CN1293093C (zh) *	2002-08-30	2007-01-03	马润林	乳头瘤病毒衣壳蛋白的原核制备和应用
ATE503492T1 (de)	2002-12-20	2011-04-15	Glaxosmithkline Biolog Sa	Verwendung von hpv16 und hpv18 vlps als vakzine gegen eine oder mehrere onkogene hpv des typus 31,33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
MY139500A (en)	2003-11-12	2009-10-30	Merck Sharp & Dohme	Optimized expression of hpv 58 l1 in yeast
CN1683010A (zh)	2005-02-06	2005-10-19	哈尔滨医科大学	人乳头瘤病毒型双价病毒样颗粒混合蛋白抗原及构建方法
CN100392084C (zh)	2006-03-13	2008-06-04	曾毅	含密码子优化型hpv16l1基因的重组腺病毒
CN101153280B (zh)	2006-09-29	2015-08-19	厦门大学	从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法
EP2129394B1 (en) *	2007-03-09	2012-06-20	Merck Sharp & Dohme Corp.	Papillomavirus vaccine compositions
US9364529B2 (en) *	2007-04-29	2016-06-14	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	Truncated L1 protein of human papillomavirus type 18
DK2154147T3 (en)	2007-04-29	2015-12-07	Beijing Wantai Biological Pharmacy Entpr Co Ltd	Truncated L1 protein of human papillomavirus 16
DK2910566T5 (en) *	2007-05-29	2016-11-07	Univ Xiamen	Truncated L1 protein of human papillomavirus 11

2008
- 2008-04-29 DK DK08748431.7T patent/DK2154147T3/en active
- 2008-04-29 CN CN2008100938168A patent/CN101293918B/zh active Active
- 2008-04-29 US US12/598,186 patent/US9428555B2/en active Active
- 2008-04-29 WO PCT/CN2008/000872 patent/WO2008134934A1/zh not_active Ceased
- 2008-04-29 EP EP08748431.7A patent/EP2154147B1/en active Active
- 2008-04-29 BR BRPI0811016-6A patent/BRPI0811016B1/pt active IP Right Grant

Also Published As

Publication number	Publication date
WO2008134934A1 (fr)	2008-11-13
DK2154147T3 (en)	2015-12-07
EP2154147B1 (en)	2015-10-07
EP2154147A4 (en)	2011-11-02
BRPI0811016B1 (pt)	2021-09-21
US9428555B2 (en)	2016-08-30
CN101293918B (zh)	2013-03-27
US20100255031A1 (en)	2010-10-07
CN101293918A (zh)	2008-10-29
EP2154147A1 (en)	2010-02-17
HK1124868A1 (en)	2009-07-24

Publication	Publication Date	Title
BRPI0811016A2 (pt)	2015-01-27	Proteína li truncada do papiloma vírus humano tipo 16
BR112012004546A2 (pt)	2016-11-29	"terapêutica por proteínas ligantes dll4-ligantes"
BRPI0813647A2 (pt)	2014-12-23	Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados
BRPI0911743A2 (pt)	2015-07-07	"peptídeo"
SI2126093T1 (sl)	2013-01-31	IzboljĹˇanje priprave proteinov
EP2215246A4 (en)	2011-08-10	PROTEIN SCAFFOLDS
DK1959991T3 (da)	2013-06-17	Terapeutisk vaccine
LT3118220T (lt)	2019-10-10	Baltymas
EP2131749A4 (en)	2014-04-02	Surgical stapling apparatus
DE602008006310D1 (de)	2011-06-01	Endoskopischer Reprozessor
BRPI1013015A2 (pt)	2016-03-29	"osteosíntese com nanoprata"
ITCO20080005A1 (it)	2009-08-20	"shaker monouso"
PL2059223T3 (pl)	2013-03-29	Kompozycja do pielęgnacji skóry
BRPI0813955A2 (pt)	2017-05-09	composições terapêuticas e o uso das mesmas
HUE047767T2 (hu)	2020-05-28	Macitentánt tartalmazó terápiás készítmények
BRPI0814971A2 (pt)	2015-02-03	Proteína
BRPI0921947A2 (pt)	2018-10-16	formulações de proteína terapêutica
EP2135596A4 (en)	2015-01-28	COSMETIC COSMETIC COMPOSITION
BRPI0817822A2 (pt)	2015-03-31	Preparação sólida farmacêutica do tipo matriz
EP2245315A4 (en)	2012-10-24	O-HEAD DESIGN
BRPI0717212A2 (pt)	2013-09-17	fralda descartÁvel tipo calÇa
BRPI0820410A2 (pt)	2015-05-19	Lactans substituídos terapêuticos
SMT201600041B (it)	2016-02-25	Agenti terapeutici 713
BRPI0818598A2 (pt)	2017-05-16	agentes terapêuticos - 802
ATE481469T1 (de)	2010-10-15	Gewebepflegezusammensetzungen

Legal Events

Date	Code	Title	Description
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-06-25	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2019-12-10	B25A	Requested transfer of rights approved	Owner name: XIAMEN UNIVERSITY (CN) ; XIAMEN INNOVAX BIOTECH CO., LTD. (CN)
2020-05-19	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-08-25	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2021-04-20	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-08-10	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-09-21	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/04/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.